Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to res... Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population. Mehr anzeigen
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone PR Newswire GAITHERSBURG, Md., Dec. 13, 2024 Novavax continues to...
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza PR Newswire GAITHERSBURG, Md., Dec. 10, 2024 Company continuing to work with the U.S. FDA on potential...
Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million PR Newswire GAITHERSBURG, Md., Dec. 4, 2024 Agreement provides significant, non-dilutive capital...
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) PR Newswire GAITHERSBURG, Md., Nov. 15, 2024 GAITHERSBURG, Md., Nov. 15, 2024 /PRNewswire/ -- Novavax, Inc...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.74 | -8.50574712644 | 8.7 | 8.7741 | 7.88 | 2234087 | 8.45210546 | CS |
| 4 | -0.82 | -9.33940774487 | 8.78 | 9.75 | 7.88 | 3413605 | 8.73362226 | CS |
| 12 | -5.74 | -41.897810219 | 13.7 | 13.7725 | 6.81 | 5133087 | 9.44700981 | CS |
| 26 | -4.71 | -37.1744277822 | 12.67 | 17.81 | 6.81 | 6003454 | 11.72055969 | CS |
| 52 | 3.14 | 65.1452282158 | 4.82 | 23.8599 | 3.5324 | 9078655 | 10.62849562 | CS |
| 156 | -144.82 | -94.7898939652 | 152.78 | 159 | 3.5324 | 7451667 | 20.22066489 | CS |
| 260 | 3.98 | 100 | 3.98 | 331.5388 | 3.5324 | 6841562 | 53.65888504 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
